About

AcouSort is an innovative technology company with high focus on products and solutions for automated preparation of biological samples for researchers and life science companies. The core technology is acoustofluidics where a combination of microfluidics and sound waves is used to separate blood into its components, to isolate and purify cells and extracellular vesicles and to perform rapid biochemical reactions. AcouSort’s core technology has been researched and developed for over 20 years at Lund University in the Department of Biomedical Engineering, research headed by Professor Thomas Laurell, board member of AcouSort. About AcouSort AB AcouSort is an innovative technology company with high focus on products and solutions for automated preparation of biological samples for researchers and life science companies. The core technology is acoustofluidics where a combination of microfluidics and sound waves is used to separate blood into its components, to isolate and purify cells and extracellular vesicles and to perform rapid biochemical reactions. AcouSort works with life science system providers integrating its automated sample processing technology into their next generation PoC dignostics or cell therapy systems. The first result of such partnerships recieved FDA and other authority approvals in 2023. AcouSort’s core technology has been researched and developed for over 20 years at Lund University in the Department of Biomedical Engineering, research headed by Professor Thomas Laurell, board member of AcouSort. About AcouSort AB AcouSort is an innovative technology company with high focus on products and solutions for automated preparation of biological samples for researchers and life science companies. The core technology is acoustofluidics where a combination of microfluidics and sound waves is used to separate blood into its components, to isolate and purify cells and extracellular vesicles and to perform rapid biochemical reactions. AcouSort works with life science system providers integrating its automated sample processing technology into their next generation PoC dignostics or cell therapy systems. The first result of such partnerships recieved FDA and other authority approvals in 2023. AcouSort’s core technology has been researched and developed for over 20 years at Lund University in the Department of Biomedical Engineering, research headed by Professor Thomas Laurell, board member of AcouSort. AcouSort provides game changing sample processing solutions for the life science and diagnostic industry. AcouSort provides solutions for diagnostic applications and cell therapy manufacturing enabling automated and integrated sample processing of cells and extracellular vesicles. Our acoustofluidic products enable automation and integration of washing, enrichment, up-concentration, optical or physical separation, and more – all while providing superior sample quality.